Delivery Order 36F79720D0227-36C25926F0197
Award Date 5/18/26
Potential Completion Date 5/17/27
Potential Value $2.4M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Boca Raton, FL 33432, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Veterans Affairs Veterans Integrated Service Network 19 awarded a $587,007.48 firm fixed-price delivery order to Exelan Pharmaceuticals Inc. on February 5, 2026, for emergency pharmacy supply of Lenalidomide with an ultimate completion date of February 8, 2026. This delivery order is issued without a set-aside designation, allowing unrestricted competition among qualified vendors. The contract will be performed at Exelan's facility in Boca Raton, Florida, where the company...
- The Department of Veterans Affairs, through Veterans Integrated Service Network 10, awarded a $2.55 million firm-fixed-price delivery order to Exelan Pharmaceuticals Inc. for the supply of Lenalidomide, an oncology medication used in the treatment of hematologic malignancies. The contract, awarded on February 1, 2026, with an ultimate completion date of July 31, 2026, carries no set-aside designation and will be performed at Exelan's facility in Boca Raton, Florida. This delivery order is issued...
- This delivery order, awarded February 6, 2026, by Veterans Integrated Service Network 17, provides for the supply of Lenalidomide oral medication to support the Department of Veterans Affairs healthcare system. Exelan Pharmaceuticals Inc., a Boca Raton, Florida-based pharmaceutical manufacturer and distributor specializing in generic and branded drug products for federal agencies, was selected as the prime contractor. The award carries a ceiling value of $899,347.26 under a firm fixed-price...
- The Department of Veterans Affairs Veterans Integrated Service Network 20 awarded a $2.53 million firm fixed-price delivery order to Exelan Pharmaceuticals Inc. for the supply of Lenalidomide capsules. This delivery order, issued on January 16, 2026, with a completion date of January 15, 2027, represents a continuation of Exelan's extensive pharmaceutical supply relationship with the VA healthcare system. The contract contains no set-aside designation, allowing full and open competition. Exelan,...
- The Department of Veterans Affairs, Veterans Integrated Service Network 23 awarded a $3.6M firm fixed-price delivery order to Exelan Pharmaceuticals Inc. for the supply of Lenalidomide Capsules. The contract was awarded on December 1, 2025, with an ultimate completion date of September 30, 2026, and carries no set-aside designation. Performance will take place in Iowa City, Iowa. This delivery order falls under the GSA Schedule Pharmaceuticals and Drugs contract vehicle (FSS-61-IB), enabling the...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 21, awarded a delivery order contract valued at $193,101.16 to Exelan Pharmaceuticals Inc. for the supply of Lenalidomide 20mg to support emergency pharmacy operations. The award, issued on November 13, 2025, is structured as a firm fixed-price delivery order with performance completion targeted for September 30, 2026. Exelan Pharmaceuticals will deliver the medication to a location in Boca Raton, Florida. This contract...
- The Department of Veterans Affairs, Veterans Integrated Service Network 23, awarded a delivery order contract to Exelan Pharmaceuticals Inc. for the supply of generic lenalidomide drug. This firm fixed-price delivery order, valued at $3.4M, was awarded on January 1, 2026, with an ultimate completion date of December 31, 2026. The contract will be performed in Boca Raton, Florida, and represents a non-competitive award with no set-aside designation. This delivery order falls under the GSA...
- The Department of Veterans Affairs, Veterans Integrated Service Network 20, awarded a delivery order to Exelan Pharmaceuticals Inc. on January 19, 2026, for the supply of Lenalidomide in various milligram strengths to support oncology treatment for veterans. This firm-fixed-price delivery order, valued at $545,433.70 with a completion date of January 18, 2027, was issued without a set-aside designation, allowing unrestricted competition among qualified vendors. The contract will be performed...
- The Department of Veterans Affairs Veterans Integrated Service Network 21 awarded an emergency delivery order to Exelan Pharmaceuticals Inc. on August 27, 2025, for the procurement of Lenalidomide in 15mg and 2.5mg formulations. This firm fixed-price contract, valued at $10,397.48, was funded through fiscal year 2025 Defense and Overseas Contingency Operations (DEOB) appropriations and carries an ultimate completion date of September 30, 2025. The award was issued without a set-aside...
- The Department of Veterans Affairs, Veterans Integrated Service Network 4, awarded a $257,809.49 firm fixed-price delivery order to Exelan Pharmaceuticals Inc. for the supply of specialty pharmaceutical Lenalidomide. The contract, which commenced on February 6, 2026, and is scheduled for completion by February 5, 2027, carries no set-aside designation and represents an unrestricted competitive award. Performance will occur at Exelan's facility located in Ottawa, Ontario, Canada. This delivery...